Literature DB >> 31526761

UNR/CSDE1 Drives a Post-transcriptional Program to Promote Melanoma Invasion and Metastasis.

Laurence Wurth, Panagiotis Papasaikas, David Olmeda, Nadine Bley, Guadalupe T Calvo, Santiago Guerrero, Daniela Cerezo-Wallis, Javier Martinez-Useros, María García-Fernández, Stefan Hüttelmaier, Maria S Soengas, Fátima Gebauer.   

Abstract

Entities:  

Year:  2019        PMID： 31526761     DOI： 10.1016/j.ccell.2019.08.013

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  5 in total

1.  Six RNA binding proteins (RBPs) related prognostic model predicts overall survival for clear cell renal cell carcinoma and is associated with immune infiltration.

Authors:  Qianwei Xing; Yi Wang
Journal:  Bosn J Basic Med Sci       Date:  2022-06-01       Impact factor: 3.759

2.  RNA-binding protein MEX3D promotes cervical carcinoma tumorigenesis by destabilizing TSC22D1 mRNA.

Authors:  Zhi Zheng; Xiaojing Chen; Xiaoyun Cai; Hui Lin; Junfen Xu; Xiaodong Cheng
Journal:  Cell Death Discov       Date:  2022-05-05

3.  Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy.

Authors:  Timothy Kottke; Jason Tonne; Laura Evgin; Christopher B Driscoll; Jacob van Vloten; Victoria A Jennings; Amanda L Huff; Brady Zell; Jill M Thompson; Phonphimon Wongthida; Jose Pulido; Matthew R Schuelke; Adel Samson; Peter Selby; Elizabeth Ilett; Mark McNiven; Lewis R Roberts; Mitesh J Borad; Hardev Pandha; Kevin Harrington; Alan Melcher; Richard G Vile
Journal:  Nat Commun       Date:  2021-03-26       Impact factor: 14.919

4.  LINC01234 Accelerates the Progression of Breast Cancer via the miR-525-5p/Cold Shock Domain-Containing E1 Axis.

Authors:  Jia Yu; Xinxin Zhang; Rongfang He; Xiaoyan Yang; Juan Hu; Fang Tan; Jinyu Yao; Xiaoyong Lei; Gebo Wen
Journal:  Dis Markers       Date:  2022-07-25       Impact factor: 3.464

Review 5.  The Role of RNA-Binding Proteins in Hematological Malignancies.

Authors:  Pedro Aguilar-Garrido; Álvaro Otero-Sobrino; Miguel Ángel Navarro-Aguadero; María Velasco-Estévez; Miguel Gallardo
Journal:  Int J Mol Sci       Date:  2022-08-23       Impact factor: 6.208
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.